Play all audios:
New insights into how NK cells are educated by the receptor NKG2D, which leads to effects on another receptor, NCR1, raise interesting questions about why so many receptors are linked to the
education of NK cells. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution
Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12
print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be
subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support
REFERENCES * Brodin, P., Kärre, K. & Höglund, P. _Trends Immunol._ 30, 143–149 (2009). Article CAS PubMed Google Scholar * He, Y. & Tian, Z. _Cell. Mol. Immunol._ 14, 321–330
(2017). Article CAS PubMed Google Scholar * Raulet, D. H. & Vance, R. E. _Nat. Rev. Immunol._ 6, 520–531 (2006). Article CAS PubMed Google Scholar * Jelenčić, V. et al. _Nat.
Immunol_. https://doi.org/10.1038/s41590-018-0209-9 (2018). * Li, W. et al. _Immunity_ 27, 763–774 (2007). Article CAS PubMed PubMed Central Google Scholar * Raulet, D. H. _Nat. Rev.
Immunol._ 3, 781–790 (2003). Article CAS PubMed Google Scholar * Koch, J., Steinle, A., Watzl, C. & Mandelboim, O. _Trends Immunol._ 34, 182–191 (2013). Article CAS PubMed Google
Scholar * He, Y. et al. _J. Autoimmun._ 81, 1–12 (2017). Article CAS PubMed Google Scholar * Wu, N. et al. _Nat. Immunol._ 17, 387–396 (2016). Article CAS PubMed Google Scholar *
Viant, C. et al. _Nat. Commun._ 5, 5108 (2014). Article CAS PubMed Google Scholar * Guia, S. et al. _Sci. Signal._ 4, ra21 (2011). Article CAS PubMed Google Scholar Download
references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Laboratory of Molecular Oncology, Institut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada André Veillette &
Yan Lu * Department of Medicine, University of Montreal, Montreal, Quebec, Canada André Veillette * Department of Medicine, McGill University, Montreal, Quebec, Canada André Veillette
Authors * André Veillette View author publications You can also search for this author inPubMed Google Scholar * Yan Lu View author publications You can also search for this author inPubMed
Google Scholar CORRESPONDING AUTHOR Correspondence to André Veillette. ETHICS DECLARATIONS COMPETING INTERESTS A.V. has a contract with Bristol Myers-Squibb to study the mechanism of action
of the monoclonal antibody elotuzumab (antibody to SLAMF7) in multiple myeloma. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Veillette, A., Lu, Y. It
takes a village. _Nat Immunol_ 19, 1046–1047 (2018). https://doi.org/10.1038/s41590-018-0213-0 Download citation * Published: 17 September 2018 * Issue Date: October 2018 * DOI:
https://doi.org/10.1038/s41590-018-0213-0 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative